Healthcare -
Biotechnology - NASDAQ - GB
$ 2.86
-1.38 %
$ 443 M
Market Cap
-9.53
P/E
MREO - OPERATING INCOME
Operating Income MREO - Mereo BioPharma Group plc
-28.4 M
LAST VALUE
-16.50%
2 YEAR CAGR
4.20%
5 YEAR CAGR
0.00%
10 YEAR CAGR